{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:14:00Z","timestamp":1789010040932,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG18387"],"award-info":[{"award-number":["IG18387"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00277-020-04178-0","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T21:02:45Z","timestamp":1594846965000},"page":"2715-2717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of \u201cdouble hit\u201d mantle cell lymphoma carrying CCND1 and MYC translocations relapsed\/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib"],"prefix":"10.1007","volume":"99","author":[{"given":"Greta","family":"Scapinello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Martines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Gurrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-623X","authenticated-orcid":false,"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"crossref","unstructured":"(1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 89(11):3909\u20133918","DOI":"10.1182\/blood.V89.11.3909"},{"issue":"3","key":"4178_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","volume":"468","author":"B Sander","year":"2016","unstructured":"Sander B, Quintanilla-Martinez L, Ott G, Xerri L, Kuzu I, Chan JK, Swerdlow SH, Campo E (2016) Mantle cell lymphoma--a spectrum from indolent to aggressive disease. Virchows Arch 468(3):245\u2013257. https:\/\/doi.org\/10.1007\/s00428-015-1840-6","journal-title":"Virchows Arch"},{"issue":"20","key":"4178_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"11","key":"4178_CR4","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1200\/JCO.2012.45.9842","volume":"31","author":"C Visco","year":"2013","unstructured":"Visco C, Finotto S, Zambello R, Paolini R, Menin A, Zanotti R, Zaja F, Semenzato G, Pizzolo G, D\u2019Amore ES, Rodeghiero F (2013) Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol 31(11):1442\u20131449. https:\/\/doi.org\/10.1200\/JCO.2012.45.9842","journal-title":"J Clin Oncol"},{"issue":"12","key":"4178_CR5","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1002\/ajh.25278","volume":"93","author":"MC Tisi","year":"2018","unstructured":"Tisi MC, Paolini R, Piazza F, Ravelli E, Tecchio C, Sartori R, Famengo B, D\u2019Amore ESG, Carli G, Perbellini O, Di Bona E, Ruggeri M, Visco C (2018) Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma. Am J Hematol 93(12):E386\u2013E389. https:\/\/doi.org\/10.1002\/ajh.25278","journal-title":"Am J Hematol"},{"issue":"2","key":"4178_CR6","first-page":"346","volume":"10","author":"C Tirier","year":"1996","unstructured":"Tirier C, Zhang Y, Plendl H, Weber-Matthiesen K, Langer W, Heit W, Schlegelberger B (1996) Simultaneous presence of t(11;14) and a variant Burkitt\u2019s translocation in the terminal phase of a mantle cell lymphoma. Leukemia 10(2):346\u2013350","journal-title":"Leukemia"},{"issue":"12","key":"4178_CR7","first-page":"4365","volume":"93","author":"S Bea","year":"1999","unstructured":"Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R, Campo E (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93(12):4365\u20134374","journal-title":"Blood"},{"issue":"1","key":"4178_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1365-2141.2001.03056.x","volume":"115","author":"UN Vaishampayan","year":"2001","unstructured":"Vaishampayan UN, Mohamed AN, Dugan MC, Bloom RE, Palutke M (2001) Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy. Br J Haematol 115(1):66\u201368. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03056.x","journal-title":"Br J Haematol"},{"issue":"12","key":"4178_CR9","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/sj.leu.2401599","volume":"13","author":"L Hernandez","year":"1999","unstructured":"Hernandez L, Hernandez S, Bea S, Pinyol M, Ferrer A, Bosch F, Nadal A, Fernandez PL, Palacin A, Montserrat E, Campo E (1999) C-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin\u2019s lymphomas. Leukemia 13(12):2087\u20132093. https:\/\/doi.org\/10.1038\/sj.leu.2401599","journal-title":"Leukemia"},{"issue":"3","key":"4178_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/his.12760","volume":"68","author":"JY Choe","year":"2016","unstructured":"Choe JY, Yun JY, Na HY, Huh J, Shin SJ, Kim HJ, Paik JH, Kim YA, Nam SJ, Jeon YK, Park G, Kim JE (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68(3):442\u2013449. https:\/\/doi.org\/10.1111\/his.12760","journal-title":"Histopathology"},{"issue":"39","key":"4178_CR11","doi-asserted-by":"publisher","first-page":"42362","DOI":"10.18632\/oncotarget.5705","volume":"6","author":"S Yi","year":"2015","unstructured":"Yi S, Zou D, Li C, Zhong S, Chen W, Li Z, Xiong W, Liu W, Liu E, Cui R, Ru K, Zhang P, Xu Y, An G, Lv R, Qi J, Wang J, Cheng T, Qiu L (2015) High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival. Oncotarget 6(39):42362\u201342371. https:\/\/doi.org\/10.18632\/oncotarget.5705","journal-title":"Oncotarget"},{"issue":"2","key":"4178_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","volume":"41","author":"Z Hu","year":"2017","unstructured":"Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, Lu X, Pham LV, Young KH, Wang W, Hu S (2017) Mantle cell lymphoma with MYC rearrangement: a report of 17 patients. Am J Surg Pathol 41(2):216\u2013224. https:\/\/doi.org\/10.1097\/PAS.0000000000000758","journal-title":"Am J Surg Pathol"},{"key":"4178_CR13","doi-asserted-by":"publisher","unstructured":"Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S (2020) MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2019.243071 haematol.2019.243071","DOI":"10.3324\/haematol.2019.243071"},{"issue":"16","key":"4178_CR14","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1182\/bloodadvances.2018016048","volume":"2","author":"J Lee","year":"2018","unstructured":"Lee J, Zhang LL, Wu W, Guo H, Li Y, Sukhanova M, Venkataraman G, Huang S, Zhang H, Alikhan M, Lu P, Guo A, Galanina N, Andrade J, Wang ML, Wang YL (2018) Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv 2(16):2039\u20132051. https:\/\/doi.org\/10.1182\/bloodadvances.2018016048","journal-title":"Blood Adv"},{"issue":"13","key":"4178_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2015-04-639542","volume":"126","author":"B Sun","year":"2015","unstructured":"Sun B, Shah B, Fiskus W, Qi J, Rajapakshe K, Coarfa C, Li L, Devaraj SG, Sharma S, Zhang L, Wang ML, Saenz DT, Krieger S, Bradner JE, Bhalla KN (2015) Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib. Blood 126(13):1565\u20131574. https:\/\/doi.org\/10.1182\/blood-2015-04-639542","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04178-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T23:41:38Z","timestamp":1626306098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04178-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04178-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The consent to publication of the material was previously obtained. The principles of the Declaration of Helsinki were followed. The Padova Province\u00a0Ethic Committee approved the work (n. 4089\/AO17).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}